[go: up one dir, main page]

UA83516C2 - Фармацевтическая композиция для лечения рассеянного склероза, содержащая цинк-гиалуронановый комплекс - Google Patents

Фармацевтическая композиция для лечения рассеянного склероза, содержащая цинк-гиалуронановый комплекс Download PDF

Info

Publication number
UA83516C2
UA83516C2 UAA200606730A UAA200606730A UA83516C2 UA 83516 C2 UA83516 C2 UA 83516C2 UA A200606730 A UAA200606730 A UA A200606730A UA A200606730 A UAA200606730 A UA A200606730A UA 83516 C2 UA83516 C2 UA 83516C2
Authority
UA
Ukraine
Prior art keywords
aai
aye
oei
eee
azabzsi
Prior art date
Application number
UAA200606730A
Other languages
English (en)
Ukrainian (uk)
Inventor
Дьордь Тибор Балог
Янош Иллеш
Андраш Борош
Габорне Форраи
Акошне Секей
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт. filed Critical Рихтер Гедеон Ведьесети Дьяр Рт.
Publication of UA83516C2 publication Critical patent/UA83516C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к фармацевтическим композициям для лечения рассеянного склероза, которые содержат в качестве активного ингредиента цинк-гиалуронановый комплекс, преимущественно цинк-гиалуронановый комплекс с молекулярной массой 800-1200 кДа, и фармацевтически приемлемый носитель и/или добавку.
UAA200606730A 2003-11-20 2004-11-18 Фармацевтическая композиция для лечения рассеянного склероза, содержащая цинк-гиалуронановый комплекс UA83516C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0303779A HUP0303779A2 (en) 2003-11-20 2003-11-20 Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
PCT/HU2004/000107 WO2005049047A1 (en) 2003-11-20 2004-11-18 Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
UA83516C2 true UA83516C2 (ru) 2008-07-25

Family

ID=90001707

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200606730A UA83516C2 (ru) 2003-11-20 2004-11-18 Фармацевтическая композиция для лечения рассеянного склероза, содержащая цинк-гиалуронановый комплекс

Country Status (19)

Country Link
US (1) US20070123488A1 (ru)
EP (1) EP1699468B1 (ru)
JP (1) JP4778908B2 (ru)
CN (1) CN1882352B (ru)
AT (1) ATE359800T1 (ru)
CY (1) CY1106617T1 (ru)
DE (1) DE602004006024T2 (ru)
DK (1) DK1699468T3 (ru)
EA (1) EA009209B1 (ru)
ES (1) ES2286698T3 (ru)
HR (1) HRP20070291T3 (ru)
HU (1) HUP0303779A2 (ru)
NO (1) NO336121B1 (ru)
PL (1) PL1699468T3 (ru)
PT (1) PT1699468E (ru)
RS (2) RS20060325A (ru)
SI (1) SI1699468T1 (ru)
UA (1) UA83516C2 (ru)
WO (1) WO2005049047A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007153761A (ja) * 2005-12-01 2007-06-21 Toshitsu Kagaku Kenkyusho:Kk シナプス伝達促進剤及びシナプス保護剤
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
NO20064337L (no) * 2005-09-26 2007-03-27 Glycoscience Lab Inc Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
CA2641571C (en) 2006-12-05 2010-01-19 Glycoscience Laboratories, Inc. Treatment of osteoarthritis
JP2007277258A (ja) * 2007-06-20 2007-10-25 Toshitsu Kagaku Kenkyusho:Kk 炎症及び神経疾患の治療剤及び予防剤
KR20140061559A (ko) * 2009-08-20 2014-05-21 에다 리서치 앤드 디벨럽먼트 컴퍼니 리미티드 글라티라머 아세테이트를 포함하는 약제
CN111647100B (zh) * 2020-07-14 2022-03-01 山东华熙海御生物医药有限公司 一种高分子量透明质酸锌的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
CA2229282C (en) * 1995-09-28 2002-01-29 Sangstat Medical Corporation Use of hyaluronic acid as an immunosuppressant
HU225991B1 (en) * 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
DE19721099C2 (de) * 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
JP2003089647A (ja) * 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
JP2001163789A (ja) * 1999-12-13 2001-06-19 Maruho Co Ltd マトリックスメタロプロテアーゼ阻害用医薬組成物
BG104880A (en) * 2000-10-24 2002-04-30 Иван ХРИСТОВ Medicamentous preparation for multiple sclerosis treatment
EP1369119B1 (en) * 2001-03-15 2008-12-17 Seikagaku Corporation Il-12 expression controlling agents

Also Published As

Publication number Publication date
US20070123488A1 (en) 2007-05-31
ATE359800T1 (de) 2007-05-15
PT1699468E (pt) 2007-06-05
EP1699468A1 (en) 2006-09-13
CN1882352B (zh) 2010-08-04
WO2005049047A1 (en) 2005-06-02
RS50523B (sr) 2010-05-07
EA200600998A1 (ru) 2006-10-27
DK1699468T3 (da) 2007-09-03
DE602004006024T2 (de) 2007-12-27
DE602004006024D1 (de) 2007-05-31
CN1882352A (zh) 2006-12-20
CY1106617T1 (el) 2012-01-25
HUP0303779A2 (en) 2006-02-28
RS20060325A (sr) 2008-08-07
ES2286698T3 (es) 2007-12-01
EA009209B1 (ru) 2007-12-28
HUP0303779D0 (en) 2004-03-01
JP4778908B2 (ja) 2011-09-21
EP1699468B1 (en) 2007-04-18
HK1098352A1 (en) 2007-07-20
HRP20070291T3 (hr) 2007-10-31
SI1699468T1 (sl) 2007-08-31
JP2007512311A (ja) 2007-05-17
PL1699468T3 (pl) 2007-09-28
NO20062857L (no) 2006-08-18
NO336121B1 (no) 2015-05-18

Similar Documents

Publication Publication Date Title
UA83516C2 (ru) Фармацевтическая композиция для лечения рассеянного склероза, содержащая цинк-гиалуронановый комплекс
US5389383A (en) Method for treating hypoxia-associated ocular complications
Hospers et al. The sulfhydryl containing compounds WR-2721 and glutathione as radio-and chemoprotective agents. A review, indications for use and prospects
AR076778A1 (es) Composiciones orales que contienen compuestos de poliguanidinio y metodos de preparacion y uso de las mismas
MX2007009973A (es) Toallas sanitarias capaces de tomar forma tridimensional compleja durante el uso.
CA2483998A1 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
ES2641169T3 (es) Derivados de poli (nitrógeno/amina) de una cera natural o un derivado alcoxilado de la misma y composiciones oftálmicas
Ortiz et al. Autocrine effects of nitric oxide on HCO3-transport by rat thick ascending limb
AU2012227308B2 (en) Topical acyl glutathione formulations
US20060103807A1 (en) Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium
CA2285649C (fr) Composition fongicide synergique
HUT75679A (en) Compositions for treating hypoxia-associated ocular complications
TR2021016287A1 (tr) Presbi̇yopi̇, kuru göz hastaliği ve bi̇lgi̇sayar görme sendromunun tedavi̇si̇ i̇çi̇n oftalmi̇k formülasyonlar
CA2883399C (en) Minimizing biological lipid deposits on contact lenses
ES2453641T3 (es) Composiciones oftálmicas que comprenden un dipéptido con un resto de glicina
CZ20013534A3 (cs) Agrochemická kompozice
ES2642038T3 (es) Utilización de una base nutritiva compleja en el campo cosmético, especialmente el capilar
Zou et al. Exogenous carbon acquisition of photosynthesis in Porphyra haitanensis (Bangiales, Rhodophyta) under emersed state
Pavlica et al. Comparison of uptake and neuroprotective potential of seven zinc-salts
Nogae et al. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells
Kiura et al. Phase I study of cisplatin, docetaxel and irinotecan for advanced non-small cell lung cancer (NSCLC)
ES2956040T3 (es) Olanexidina como agente antiinflamatorio
Sawada et al. Phase I study of docetaxel (DTX) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC)
Gaafar et al. Phase II study of Gemcitabine and Cisplatin in advanced non small cell lung cancer: Experience from Egypt
Qingyun et al. Genetic fingerprinting of plankton community provides new insights into aquatic ecology